Hims & Hers Health Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Hims & Hers Health Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
/ 
Hims & Hers Health, Inc. (HIMS) is a U.S.-based telehealth company that offers direct-to-consumer healthcare services and wellness products through a digital platform. Founded in 2017 and headquartered in San Francisco, California, the company connects users with licensed healthcare professionals for the treatment of common conditions in mental health, dermatology, sexual health, and primary care.
Through its website and mobile app, Hims & Hers enables users to complete virtual consultations—often asynchronously—and receive personalised treatment plans, with medications and wellness products delivered to their homes. The company operates under two consumer-facing brands: Hims (targeting men) and Hers (targeting women), both of which offer subscription-based access to prescription and over-the-counter products.
Hims & Hers also sells wellness and personal care items through e-commerce and retail partnerships. Its vertically integrated model combines pharmacy fulfilment, clinical operations, and proprietary technology to enhance accessibility, affordability, and user experience across routine and preventive care.
Hims & Hers Health is listed on the New York Stock Exchange (NYSE).
